The Relative Strength (RS) Rating for Masimo moved into a higher percentile Monday, as it got a lift from 67 to 72.
Can You Really Time The Stock Market?
This unique rating tracks technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the trailing 52 weeks stacks up against all the other stocks in our database.
History reveals that the best-performing stocks often have an 80 or better RS Rating as they launch their largest price moves. See if Masimo can continue to rebound and clear that threshold.
Masimo is building a consolidation with a 194.88 buy point. See if it can break out in heavy volume.
Regarding fundamentals, the company has posted rising EPS growth in each of the last four reports. Sales gains have also risen over the same time frame. The company is expected to report its next quarterly numbers on or around Aug. 5.
The company earns the No. 2 rank among its peers in the Medical-Systems/Equipment industry group. iRadimed is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
